{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "IN a rare interview, Lauren Bacall appeared on the NBC ''Today'' program in March, telling Matt Lauer about a good friend who had gone blind from an eye disease and urging the audience to see their doctors to be tested for it. ''It's just -- it's frightening because it -- it can happen very suddenly,'' she said. Ms. Bacall then mentioned a drug called Visudyne, a new treatment for the disease known as macular degeneration.", "headline": {"main": "Heartfelt Advice, Hefty Fees"}, "abstract": "Dozens of celebrities, including Lauren Bacall, Kathleen Turner and Rob Lowe, get hefty fees from drug makers to disclose in television appearances intimate details about ailments that afflict them or people close to them; often mention drugs without revealing payments from manufacturers; drug makers have greatly increased promotional spending in quest to wring more profit out of their drugs before patents expire; photos; graph of promotional spending (M)", "print_page": "1", "word_count": 2958, "_id": "4fd21eee8eb7c8105d7a1a42", "snippet": "IN a rare interview, Lauren Bacall appeared on the NBC ''Today'' program in March, telling Matt Lauer about a good friend who had gone blind from an eye disease and urging the audience to see their doctors to be tested for it.    ''It's just -- it's...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/11/business/heartfelt-advice-hefty-fees.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LOWE, ROB"}, {"name": "persons", "value": "BACALL, LAUREN"}, {"name": "persons", "value": "TURNER, KATHLEEN"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "TELEVISION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "PUBLIC RELATIONS AND PUBLICITY"}, {"name": "subject", "value": "INVENTIONS AND PATENTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-08-11T00:00:00Z", "section_name": "Technology; Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a puzzling and intriguing side effect, a new antileukemia drug has darkened the gray hair of some patients, French doctors reported yesterday. The drug, Gleevec, can damage the liver and blood, making its use as a color-restoring agent unlikely. But the finding raises the possibility that a safer drug may someday be developed to serve that purpose.", "headline": {"main": "Leukemia Drug Side Effect: Color Returned to Gray Hair"}, "abstract": "French doctors report that new antileukemia drug has darkened gray hair of some patients; drug, Gleevec, manufactured by Novartis, can damage liver and blood, making its use as color-restoring agent unlikely, but finding raises possibility that safe drug may someday be developed to serve that purpose (S)", "print_page": "20", "word_count": 409, "_id": "4fd236298eb7c8105d7c7d7f", "snippet": "In a puzzling and intriguing side effect, a new antileukemia drug has darkened the gray hair of some patients, French doctors reported yesterday.    The drug, Gleevec, can damage the liver and blood, making its use as a color-restoring agent...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/08/08/us/leukemia-drug-side-effect-color-returned-to-gray-hair.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NOVARTIS AG"}, {"name": "subject", "value": "LIVER"}, {"name": "subject", "value": "LEUKEMIA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "BLOOD"}, {"name": "subject", "value": "GLEEVEC (DRUG)"}, {"name": "subject", "value": "HAIR"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "2002-08-08T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 2, "offset": 0, "time": 55}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}